Eton Pharmaceuticals, Inc.
ETON
$17.19
-$0.27-1.55%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 25.38M | 17.42M | 14.94M | 20.26M | 17.69M |
Total Receivables | 14.45M | 16.40M | 5.36M | 5.59M | 4.87M |
Inventory | 23.79M | 13.62M | 15.23M | 1.94M | 2.07M |
Prepaid Expenses | 4.82M | 2.52M | 5.49M | 1.96M | 799.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 68.44M | 49.96M | 41.02M | 29.75M | 25.43M |
|
|||||
Total Current Assets | 68.44M | 49.96M | 41.02M | 29.75M | 25.43M |
Net Property, Plant & Equipment | 342.00K | 180.00K | 209.00K | 226.00K | 255.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 32.88M | 33.88M | 34.88M | 5.85M | 6.12M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 12.00K | 12.00K | 12.00K | 12.00K | 12.00K |
Total Assets | 101.68M | 84.03M | 76.12M | 35.84M | 31.82M |
|
|||||
Total Accounts Payable | 12.14M | 4.87M | 4.17M | 2.68M | 2.13M |
Total Accrued Expenses | 23.66M | 20.40M | 15.70M | 12.85M | 11.35M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 2.79M | 77.00K | 76.00K | 4.20M | 4.73M |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 38.60M | 25.35M | 19.95M | 19.73M | 18.22M |
|
|||||
Total Current Liabilities | 38.60M | 25.35M | 19.95M | 19.73M | 18.22M |
Long-Term Debt | 27.41M | 29.99M | 29.81M | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 492.00K | 87.00K | 107.00K | 126.00K | 145.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 11.22M | 4.15M | 1.83M | -- | -- |
Total Liabilities | 77.72M | 59.58M | 51.70M | 19.86M | 18.36M |
|
|||||
Common Stock & APIC | 136.01M | 133.92M | 132.32M | 123.28M | 121.38M |
Retained Earnings | -112.05M | -109.47M | -107.89M | -107.30M | -107.92M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 23.96M | 24.45M | 24.43M | 15.98M | 13.46M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 23.96M | 24.45M | 24.43M | 15.98M | 13.46M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 23.96M | 24.45M | 24.43M | 15.98M | 13.46M |
|